Cargando…

Association of circulating adipsin with nonalcoholic fatty liver disease in obese adults: a cross-sectional study

BACKGROUND: As a secreted adipokine, adipsin has been recently shown to play a pivotal role in metabolic disorders. However, information regarding the association of circulating adipsin with non-alcoholic fatty liver disease (NAFLD) in humans is scant. METHODS: We recruited 1163 obese adult subjects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jinhua, Li, Kangli, Pan, Lingling, Teng, Fei, Zhang, Peizhen, Lin, Bingquan, Yuan, Youwen, Wei, Xueyun, Li, Wenyuan, Zhang, Huijie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981882/ https://www.ncbi.nlm.nih.gov/pubmed/33743586 http://dx.doi.org/10.1186/s12876-021-01721-9

Ejemplares similares

Circulating adipsin is associated with asymptomatic carotid atherosclerosis in obese adults
por: Zhang, Jinhua, et al.
Publicado: (2021)

Adiposity Measurements and Metabolic Syndrome Are Linked Through Circulating Neuregulin 4 and Adipsin Levels in Obese Adults
por: Guo, Dan, et al.
Publicado: (2021)

Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice
por: Yuan, Youwen, et al.
Publicado: (2022)

Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial
por: Wei, Xueyun, et al.
Publicado: (2023)

Associations of Menstrual Cycle Regularity and Length With Cardiovascular Diseases: A Prospective Study From UK Biobank
por: Huang, Chensihan, et al.
Publicado: (2023)

Circulating periostin in relation to insulin resistance and nonalcoholic fatty liver disease among overweight and obese subjects
por: Yang, Zhen, et al.
Publicado: (2016)

Adipsin Concentrations Are Associated with Back Pain Independently of Adiposity in Overweight or Obese Adults
por: Brady, Sharmayne R. E., et al.
Publicado: (2018)

Exercise Promotes Bone Marrow Microenvironment by Inhibiting Adipsin in Diet-Induced Male Obese Mice
por: Shi, Zunhan, et al.
Publicado: (2022)

Increased Serum Adipsin Correlates with MAFLD and Metabolic Risk Abnormalities
por: Pan, Jie, et al.
Publicado: (2023)

Adipsin Serum Concentrations and Adipose Tissue Expression in People with Obesity and Type 2 Diabetes
por: Milek, Margarete, et al.
Publicado: (2022)

Circulating Citrate Is Associated with Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
por: Amjad, Waseem, et al.
Publicado: (2023)

Serum Adipsin Levels throughout Normal Pregnancy and Preeclampsia
por: Poveda, Natalia E., et al.
Publicado: (2016)

Regulation of Adipsin Expression by Endoplasmic Reticulum Stress in Adipocytes
por: Ryu, Ka-Young, et al.
Publicado: (2020)

Expression of FABP4, adipsin and adiponectin in Paneth cells is modulated by gut Lactobacillus
por: Su, Xiaomin, et al.
Publicado: (2015)

Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism
por: Zhang, Xuebin, et al.
Publicado: (2023)

Combined effect of obesity and uric acid on nonalcoholic fatty liver disease and hypertriglyceridemia
por: Zhang, Shujun, et al.
Publicado: (2017)

The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves’ Orbitopathy
por: Byeon, Hyeong Ju, et al.
Publicado: (2023)

Comparison of Clinical Characteristics Between Obese and Non-Obese Patients with Nonalcoholic Fatty Liver Disease (NAFLD)
por: Li, Yifang, et al.
Publicado: (2021)

Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells
por: Aaron, Nicole, et al.
Publicado: (2021)

A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease
por: Tan, Youwen, et al.
Publicado: (2014)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver
por: Lehmann, Rainer, et al.
Publicado: (2013)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Prolactin is a Key Factor for Nonalcoholic Fatty Liver Disease in Obese Children
por: Zhang, Jianwei, et al.
Publicado: (2023)

Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines
por: Natarajan, Renuka, et al.
Publicado: (2015)

Update on Berberine in Nonalcoholic Fatty Liver Disease
por: Liu, Yang, et al.
Publicado: (2013)

Lean nonalcoholic fatty liver disease and sarcopenia
por: Chen, Milian, et al.
Publicado: (2023)

Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease
por: Kim, Tae Hyung, et al.
Publicado: (2021)

Elevated circulating Gpnmb levels are associated with hyperthyroidism
por: Lin, Jiayang, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity
por: Zhou, Xuelian, et al.
Publicado: (2022)

Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease
por: Jin, Li-ting, et al.
Publicado: (2023)

Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease
por: Ohtsuki, Tomohiro, et al.
Publicado: (2019)

In vivo protective effect of adipsin-deficiency on spontaneous knee osteoarthritis in aging mice
por: Paré, Frédéric, et al.
Publicado: (2020)

Plasma Adipsin as a Biomarker and Its Implication in Type 2 Diabetes Mellitus
por: Tafere, Gebrehiwot Gebremedhin, et al.
Publicado: (2020)

Adipsin of the Alternative Complement Pathway Is a Potential Predictor for Preeclampsia in Early Pregnancy
por: Liu, Min, et al.
Publicado: (2021)

Plasma and aqueous levels of alarin and adipsin ın patients with and without diabetic retinopathy
por: Gül, Fatih Cem, et al.
Publicado: (2022)

Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity
por: Peng, Luting, et al.
Publicado: (2021)

Macrophage metabolism in nonalcoholic fatty liver disease
por: Zhang, Wenhui, et al.
Publicado: (2023)

Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity
por: Zhang, Junfeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i9adkqj8pslfarbad2nmrple6r